Injectable routes typically provide more consistent systemic exposure and may be preferred for non-gastrointestinal applications requiring tissue delivery beyond the digestive tract
Common experiences include mild nausea during dose escalation (typically subsiding within days), changes in appetite, and rarely, pancreatitis or thyroid concerns
Who Is a Good Candidate for Semaglutide Weight Loss Treatment
Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al
This causes reduced spontaneous calorie consumption in experiments, with subjects noting 20 to 30 percent decreases in daily calorie intake relative to baseline
The clock can also vary based on where you live, where you were treated, or where the product was marketed